معرفی
Professor Ammar Al-Chalabi is a leading academic and clinician at King’s College London, serving as Professor of Neurology and Complex Disease Genetics. He directs the King’s Motor Neuron Disease Care and Research Centre and is a consultant neurologist at King's College Hospital. His research focuses on ALS etiology, modifiers, and therapies, with leadership roles in global initiatives like Project MinE and the UK MND Research Institute. He holds prestigious awards including the UK Academy of Medical Sciences Fellowship and the Healey Center International Prize. His work spans clinical trials, genetic epidemiology, and translational medicine, emphasizing patient-centered innovation.
Research interests include ALS genetics, computational analytics, and clinical trial design. Notable collaborations include work with institutions like the Perron Institute and Massachusetts General Hospital. Recent achievements include over £1.5M in grant funding for treatment acceleration and his election as a medical sciences Fellow. He co-leads the MND Register and the MND Translational Accelerator program, advancing both basic and clinical research.
His scientific awards reflect global recognition for contributions to ALS research and patient care. Key publications investigate genetic variants, therapeutic approaches, and clinical outcomes. Current projects like the RHAPSODY Study explore speech phenotyping for neurodegenerative disorders. Al-Chalabi’s interdisciplinary approach integrates genomics, computational tools, and clinical practice to address unmet needs in motor neuron disease management.
